Boone Capital Management LLC
In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 14, 2024), Boone Capital Management LLC reported 17 stock positions worth $385.8 million. Its top holding was Unum (UNM) at 14.9% of the portfolio, followed by Globus Medical Class A (GMED, 12.1%) and Cigna (CI, 11.8%). Compared with Q2 2024, it opened 2 new positions, sold out of 4, added to 6 and reduced 8. The biggest buy was a new position in Chemed (CHE) and the biggest sale an exit from Charles River Laboratories (CRL).
- Most Recent 13F
- Q2 2026
- Location
- ATLANTA, GA
- CIK
- 0001882053
- Portfolio Value
- $385.8M (Q3 2024)
- SEC Filing
- 0001214659-24-019123 ↗ filed Nov 14, 2024
Holdings Value
Holdings 17 stocks · $385.8M
| UNM Unum Group | 14.86% | 964,170 | $57.3M | Add +3.6% |
| GMED Globus Medical Inc. Class A | 12.09% | 651,710 | $46.6M | Add +2.3% |
| CI The Cigna Group | 11.85% | 131,926 | $45.7M | No change |
| MOH Molina Healthcare Inc. | 6.40% | 71,704 | $24.7M | Reduce -27.6% |
| CHE Chemed Corp. | 6.14% | 39,422 | $23.7M | New |
| PNTG The Pennant Group Inc. | 5.93% | 641,255 | $22.9M | Reduce -8.4% |
| MIRM Mirum Pharmaceuticals Inc. | 5.50% | 543,843 | $21.2M | Add +3.9% |
| DHR Danaher Corp. | 4.42% | 61,327 | $17.1M | Reduce -42.3% |
| IDYA Ideaya Biosciences Inc. | 4.37% | 531,630 | $16.8M | Add +26.0% |
| BAX Baxter International Inc. | 4.35% | 441,821 | $16.8M | Reduce -38.7% |
| BERY Berry Global Group Inc. | 4.32% | 244,982 | $16.7M | Reduce -5.7% |
| IQV Iqvia Holdings Inc. | 4.15% | 67,582 | $16.0M | Reduce -28.7% |
| AMPH Amphastar Pharmaceuticals Inc. | 3.98% | 316,556 | $15.4M | Reduce -36.1% |
| OFIX Orthofix Medical Inc. | 3.77% | 930,507 | $14.5M | Add +20.0% |
| VKTX Viking Therapeutics Inc. | 3.17% | 192,889 | $12.2M | Add +10.4% |
| PRGO Perrigo Co. PLC | 3.07% | 452,221 | $11.9M | New |
| CERT Certara Inc. | 1.64% | 541,830 | $6.3M | Reduce -24.6% |
Portfolio Sells Q2 2024 → Q3 2024
| CRL Charles River Laboratories | Sold out | 0.00% | −2.60 |
| XENE Xenon Pharmaceuticals Inc. | Sold out | 0.00% | −2.55 |
| DHR Danaher Corp. | Reduce -42.3% | 4.42% | −2.51 |
| HCSG Healthcare Services Group | Sold out | 0.00% | −2.41 |
| BAX Baxter International Inc. | Reduce -38.7% | 4.35% | −1.94 |
| TARS Tarsus Pharmaceuticals Inc. | Sold out | 0.00% | −1.53 |
| MOH Molina Healthcare Inc. | Reduce -27.6% | 6.40% | −1.28 |
| AMPH Amphastar Pharmaceuticals Inc. | Reduce -36.1% | 3.98% | −1.18 |
| IQV Iqvia Holdings Inc. | Reduce -28.7% | 4.15% | −1.07 |
| CERT Certara Inc. | Reduce -24.6% | 1.64% | −0.95 |
| BERY Berry Global Group Inc. | Reduce -5.7% | 4.32% | +0.33 |
| PNTG The Pennant Group Inc. | Reduce -8.4% | 5.93% | +1.70 |
Portfolio Buys Q2 2024 → Q3 2024
| CHE Chemed Corp. | New | 6.14% | +6.14 |
| PRGO Perrigo Co. PLC | New | 3.07% | +3.07 |
| UNM Unum Group | Add +3.6% | 14.86% | +2.45 |
| OFIX Orthofix Medical Inc. | Add +20.0% | 3.77% | +1.09 |
| MIRM Mirum Pharmaceuticals Inc. | Add +3.9% | 5.50% | +0.83 |
| VKTX Viking Therapeutics Inc. | Add +10.4% | 3.17% | +0.75 |
| GMED Globus Medical Inc. Class A | Add +2.3% | 12.09% | +0.70 |
| IDYA Ideaya Biosciences Inc. | Add +26.0% | 4.37% | +0.50 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 16 | $427.5M | TFX, MIRM, CI, IONS, UNH |
| Q1 2026 | 13 | $326.4M | MIRM, IONS, CI, MDT, TFX |
| Q4 2025 | 15 | $318.6M | MDT, MIRM, IONS, CI, BMRN |
| Q3 2025 | 16 | $305.0M | MDT, MIRM, IONS, CI, BBIO |
| Q2 2025 | 11 | $233.2M | MDT, MIRM, BMRN, AVTR, UNM |
| Q1 2025 | 12 | $293.8M | UNM, MDT, MIRM, GMED, CI |
| Q4 2024 | 13 | $296.5M | UNM, GMED, PRGO, MIRM, MOH |
| Q3 2024 | 17 | $385.8M | UNM, GMED, CI, MOH, CHE |
| Q2 2024 | 19 | $383.4M | UNM, GMED, CI, MOH, DHR |
| Q1 2024 | 21 | $494.4M | UNM, CI, MOH, ENOV, BAX |